Loading…

Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals

We have studied the role of src family tyrosine kinases in regulating synaptic transmitter release from rat brain synaptosomes by using two assays that measure different aspects of synaptic vesicle exocytosis: glutamate release (that directly measures exocytosis of vesicle contents) and release of F...

Full description

Saved in:
Bibliographic Details
Published in:Neurochemistry international 2006-07, Vol.49 (1), p.80-86
Main Authors: Baldwin, Monique L., Cammarota, Martín, Sim, Alistair T.R., Rostas, John A.P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3
cites cdi_FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3
container_end_page 86
container_issue 1
container_start_page 80
container_title Neurochemistry international
container_volume 49
creator Baldwin, Monique L.
Cammarota, Martín
Sim, Alistair T.R.
Rostas, John A.P.
description We have studied the role of src family tyrosine kinases in regulating synaptic transmitter release from rat brain synaptosomes by using two assays that measure different aspects of synaptic vesicle exocytosis: glutamate release (that directly measures exocytosis of vesicle contents) and release of FM 2–10 styryl dye (that is proportional to the time the synaptic vesicle is fused to the plasma membrane). Depolarisation was induced by KCl (30 mM) or 4-aminopyridine (4AP: 0.3 mM) to induce release by full fusion (FF) exocytosis, or by 1 mM 4AP to induce release by both FF and kiss-and-run (KR)-like exocytosis. The src family selective inhibitor, PP1 (10 μM), increased KCl and 0.3 mM 4AP-evoked Ca 2+-dependent release of glutamate, but had little effect upon exocytosis evoked by 1 mM 4AP. PP1 did not affect the release of FM 2–10 under any of the depolarisation conditions used. PP1 also had no effect on overall intracellular calcium levels, as measured by FURA2, suggesting that the effects of the inhibitor are downstream of calcium entry. At the same concentration the inactive analogue of this compound, PP3, had no effect on any measure. Immunoblotting with an antibody to phosphotyrosine revealed that phosphorylation of many synaptosomal proteins was reduced by PP1. The immunoreactivity of three protein bands increased upon depolarisation and this increase was blocked by PP1. Phosphorylation of src at tyrosine-416 was reduced by PP1 but changes in its phosphorylation did not correlate with the effects of PP1 on release. These results suggest one or more members of the src family of tyrosine kinases is a negative regulator of the KR mode of exocytosis in synaptosomes, perhaps by tonically inhibiting KR under normal stimulation conditions.
doi_str_mv 10.1016/j.neuint.2006.01.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67968355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019701860600026X</els_id><sourcerecordid>17168359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoMo7rj6D0RycW_dJul8dF8EWVwVFjzsepSQjwpk7E6vSXpx_r0ZZmBveqqCeuqleAqht5T0lFD5Yd8n2GKqPSNE9oT2hLBnaEdHxbpJCf4c7QidVEfoKC_Qq1L2hBA1EfESXVApWj_QHfp5lx0OZonzAddDXktMgH_FZAoU7GMIkCHVaOY2X1a_zaYChj-rO9TGFhzyuuBsKrbZxIQT5EfAFfLSIubyGr0IrcCbc71EP24-319_7W6_f_l2_em2c5zR2kEYiLUDC0YGxhlzigvv_UiF5NYIJpkbh0kEZy2h3prBKgoTFYGDGzkLwyW6OuU-5PX3BqXqJRYH82wSrFvRUk1yHIT4L0gVPYJTA_kJdM1JyRD0Q46LyQdNiT7613t98q-P_jWhuvlva-_O-ZtdwD8tnYU34P0ZMMWZOWSTXCxPnBrbiwbeuI8nDpq2xwhZFxchOfAxg6var_Hfl_wFpHOnhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17168359</pqid></control><display><type>article</type><title>Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals</title><source>ScienceDirect Journals</source><creator>Baldwin, Monique L. ; Cammarota, Martín ; Sim, Alistair T.R. ; Rostas, John A.P.</creator><creatorcontrib>Baldwin, Monique L. ; Cammarota, Martín ; Sim, Alistair T.R. ; Rostas, John A.P.</creatorcontrib><description>We have studied the role of src family tyrosine kinases in regulating synaptic transmitter release from rat brain synaptosomes by using two assays that measure different aspects of synaptic vesicle exocytosis: glutamate release (that directly measures exocytosis of vesicle contents) and release of FM 2–10 styryl dye (that is proportional to the time the synaptic vesicle is fused to the plasma membrane). Depolarisation was induced by KCl (30 mM) or 4-aminopyridine (4AP: 0.3 mM) to induce release by full fusion (FF) exocytosis, or by 1 mM 4AP to induce release by both FF and kiss-and-run (KR)-like exocytosis. The src family selective inhibitor, PP1 (10 μM), increased KCl and 0.3 mM 4AP-evoked Ca 2+-dependent release of glutamate, but had little effect upon exocytosis evoked by 1 mM 4AP. PP1 did not affect the release of FM 2–10 under any of the depolarisation conditions used. PP1 also had no effect on overall intracellular calcium levels, as measured by FURA2, suggesting that the effects of the inhibitor are downstream of calcium entry. At the same concentration the inactive analogue of this compound, PP3, had no effect on any measure. Immunoblotting with an antibody to phosphotyrosine revealed that phosphorylation of many synaptosomal proteins was reduced by PP1. The immunoreactivity of three protein bands increased upon depolarisation and this increase was blocked by PP1. Phosphorylation of src at tyrosine-416 was reduced by PP1 but changes in its phosphorylation did not correlate with the effects of PP1 on release. These results suggest one or more members of the src family of tyrosine kinases is a negative regulator of the KR mode of exocytosis in synaptosomes, perhaps by tonically inhibiting KR under normal stimulation conditions.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/j.neuint.2006.01.002</identifier><identifier>PMID: 16500731</identifier><identifier>CODEN: NEUIDS</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>4-Aminopyridine - pharmacology ; Animals ; Biological and medical sciences ; Brain - enzymology ; Brain - physiopathology ; Calcium Signaling - drug effects ; Calcium Signaling - physiology ; Depolarisation ; Down-Regulation - drug effects ; Down-Regulation - physiology ; Enzyme Inhibitors - pharmacology ; Exocytosis ; Exocytosis - drug effects ; Exocytosis - physiology ; Feedback, Physiological - drug effects ; Feedback, Physiological - physiology ; Fundamental and applied biological sciences. Psychology ; Fura-2 ; Glutamic Acid - metabolism ; Membrane Fusion - drug effects ; Membrane Fusion - physiology ; Nerve Tissue Proteins - drug effects ; Nerve Tissue Proteins - metabolism ; Phosphorylation - drug effects ; Potassium Channel Blockers - pharmacology ; Potassium Chloride - pharmacology ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - enzymology ; Presynaptic Terminals - secretion ; Pyrazoles - pharmacology ; Pyridinium Compounds ; Pyrimidines - pharmacology ; Quaternary Ammonium Compounds ; Rats ; Src ; src-Family Kinases - antagonists &amp; inhibitors ; src-Family Kinases - metabolism ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology ; Synaptic Vesicles - drug effects ; Synaptic Vesicles - enzymology ; Synaptosomes ; Vertebrates: nervous system and sense organs</subject><ispartof>Neurochemistry international, 2006-07, Vol.49 (1), p.80-86</ispartof><rights>2006 Elsevier Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3</citedby><cites>FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17879034$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16500731$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baldwin, Monique L.</creatorcontrib><creatorcontrib>Cammarota, Martín</creatorcontrib><creatorcontrib>Sim, Alistair T.R.</creatorcontrib><creatorcontrib>Rostas, John A.P.</creatorcontrib><title>Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>We have studied the role of src family tyrosine kinases in regulating synaptic transmitter release from rat brain synaptosomes by using two assays that measure different aspects of synaptic vesicle exocytosis: glutamate release (that directly measures exocytosis of vesicle contents) and release of FM 2–10 styryl dye (that is proportional to the time the synaptic vesicle is fused to the plasma membrane). Depolarisation was induced by KCl (30 mM) or 4-aminopyridine (4AP: 0.3 mM) to induce release by full fusion (FF) exocytosis, or by 1 mM 4AP to induce release by both FF and kiss-and-run (KR)-like exocytosis. The src family selective inhibitor, PP1 (10 μM), increased KCl and 0.3 mM 4AP-evoked Ca 2+-dependent release of glutamate, but had little effect upon exocytosis evoked by 1 mM 4AP. PP1 did not affect the release of FM 2–10 under any of the depolarisation conditions used. PP1 also had no effect on overall intracellular calcium levels, as measured by FURA2, suggesting that the effects of the inhibitor are downstream of calcium entry. At the same concentration the inactive analogue of this compound, PP3, had no effect on any measure. Immunoblotting with an antibody to phosphotyrosine revealed that phosphorylation of many synaptosomal proteins was reduced by PP1. The immunoreactivity of three protein bands increased upon depolarisation and this increase was blocked by PP1. Phosphorylation of src at tyrosine-416 was reduced by PP1 but changes in its phosphorylation did not correlate with the effects of PP1 on release. These results suggest one or more members of the src family of tyrosine kinases is a negative regulator of the KR mode of exocytosis in synaptosomes, perhaps by tonically inhibiting KR under normal stimulation conditions.</description><subject>4-Aminopyridine - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - enzymology</subject><subject>Brain - physiopathology</subject><subject>Calcium Signaling - drug effects</subject><subject>Calcium Signaling - physiology</subject><subject>Depolarisation</subject><subject>Down-Regulation - drug effects</subject><subject>Down-Regulation - physiology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Exocytosis</subject><subject>Exocytosis - drug effects</subject><subject>Exocytosis - physiology</subject><subject>Feedback, Physiological - drug effects</subject><subject>Feedback, Physiological - physiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fura-2</subject><subject>Glutamic Acid - metabolism</subject><subject>Membrane Fusion - drug effects</subject><subject>Membrane Fusion - physiology</subject><subject>Nerve Tissue Proteins - drug effects</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Potassium Chloride - pharmacology</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - enzymology</subject><subject>Presynaptic Terminals - secretion</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyridinium Compounds</subject><subject>Pyrimidines - pharmacology</subject><subject>Quaternary Ammonium Compounds</subject><subject>Rats</subject><subject>Src</subject><subject>src-Family Kinases - antagonists &amp; inhibitors</subject><subject>src-Family Kinases - metabolism</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><subject>Synaptic Vesicles - drug effects</subject><subject>Synaptic Vesicles - enzymology</subject><subject>Synaptosomes</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkU2LFDEQhoMo7rj6D0RycW_dJul8dF8EWVwVFjzsepSQjwpk7E6vSXpx_r0ZZmBveqqCeuqleAqht5T0lFD5Yd8n2GKqPSNE9oT2hLBnaEdHxbpJCf4c7QidVEfoKC_Qq1L2hBA1EfESXVApWj_QHfp5lx0OZonzAddDXktMgH_FZAoU7GMIkCHVaOY2X1a_zaYChj-rO9TGFhzyuuBsKrbZxIQT5EfAFfLSIubyGr0IrcCbc71EP24-319_7W6_f_l2_em2c5zR2kEYiLUDC0YGxhlzigvv_UiF5NYIJpkbh0kEZy2h3prBKgoTFYGDGzkLwyW6OuU-5PX3BqXqJRYH82wSrFvRUk1yHIT4L0gVPYJTA_kJdM1JyRD0Q46LyQdNiT7613t98q-P_jWhuvlva-_O-ZtdwD8tnYU34P0ZMMWZOWSTXCxPnBrbiwbeuI8nDpq2xwhZFxchOfAxg6var_Hfl_wFpHOnhw</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Baldwin, Monique L.</creator><creator>Cammarota, Martín</creator><creator>Sim, Alistair T.R.</creator><creator>Rostas, John A.P.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20060701</creationdate><title>Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals</title><author>Baldwin, Monique L. ; Cammarota, Martín ; Sim, Alistair T.R. ; Rostas, John A.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>4-Aminopyridine - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - enzymology</topic><topic>Brain - physiopathology</topic><topic>Calcium Signaling - drug effects</topic><topic>Calcium Signaling - physiology</topic><topic>Depolarisation</topic><topic>Down-Regulation - drug effects</topic><topic>Down-Regulation - physiology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Exocytosis</topic><topic>Exocytosis - drug effects</topic><topic>Exocytosis - physiology</topic><topic>Feedback, Physiological - drug effects</topic><topic>Feedback, Physiological - physiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fura-2</topic><topic>Glutamic Acid - metabolism</topic><topic>Membrane Fusion - drug effects</topic><topic>Membrane Fusion - physiology</topic><topic>Nerve Tissue Proteins - drug effects</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Potassium Chloride - pharmacology</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - enzymology</topic><topic>Presynaptic Terminals - secretion</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyridinium Compounds</topic><topic>Pyrimidines - pharmacology</topic><topic>Quaternary Ammonium Compounds</topic><topic>Rats</topic><topic>Src</topic><topic>src-Family Kinases - antagonists &amp; inhibitors</topic><topic>src-Family Kinases - metabolism</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><topic>Synaptic Vesicles - drug effects</topic><topic>Synaptic Vesicles - enzymology</topic><topic>Synaptosomes</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baldwin, Monique L.</creatorcontrib><creatorcontrib>Cammarota, Martín</creatorcontrib><creatorcontrib>Sim, Alistair T.R.</creatorcontrib><creatorcontrib>Rostas, John A.P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baldwin, Monique L.</au><au>Cammarota, Martín</au><au>Sim, Alistair T.R.</au><au>Rostas, John A.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>49</volume><issue>1</issue><spage>80</spage><epage>86</epage><pages>80-86</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><coden>NEUIDS</coden><abstract>We have studied the role of src family tyrosine kinases in regulating synaptic transmitter release from rat brain synaptosomes by using two assays that measure different aspects of synaptic vesicle exocytosis: glutamate release (that directly measures exocytosis of vesicle contents) and release of FM 2–10 styryl dye (that is proportional to the time the synaptic vesicle is fused to the plasma membrane). Depolarisation was induced by KCl (30 mM) or 4-aminopyridine (4AP: 0.3 mM) to induce release by full fusion (FF) exocytosis, or by 1 mM 4AP to induce release by both FF and kiss-and-run (KR)-like exocytosis. The src family selective inhibitor, PP1 (10 μM), increased KCl and 0.3 mM 4AP-evoked Ca 2+-dependent release of glutamate, but had little effect upon exocytosis evoked by 1 mM 4AP. PP1 did not affect the release of FM 2–10 under any of the depolarisation conditions used. PP1 also had no effect on overall intracellular calcium levels, as measured by FURA2, suggesting that the effects of the inhibitor are downstream of calcium entry. At the same concentration the inactive analogue of this compound, PP3, had no effect on any measure. Immunoblotting with an antibody to phosphotyrosine revealed that phosphorylation of many synaptosomal proteins was reduced by PP1. The immunoreactivity of three protein bands increased upon depolarisation and this increase was blocked by PP1. Phosphorylation of src at tyrosine-416 was reduced by PP1 but changes in its phosphorylation did not correlate with the effects of PP1 on release. These results suggest one or more members of the src family of tyrosine kinases is a negative regulator of the KR mode of exocytosis in synaptosomes, perhaps by tonically inhibiting KR under normal stimulation conditions.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>16500731</pmid><doi>10.1016/j.neuint.2006.01.002</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0197-0186
ispartof Neurochemistry international, 2006-07, Vol.49 (1), p.80-86
issn 0197-0186
1872-9754
language eng
recordid cdi_proquest_miscellaneous_67968355
source ScienceDirect Journals
subjects 4-Aminopyridine - pharmacology
Animals
Biological and medical sciences
Brain - enzymology
Brain - physiopathology
Calcium Signaling - drug effects
Calcium Signaling - physiology
Depolarisation
Down-Regulation - drug effects
Down-Regulation - physiology
Enzyme Inhibitors - pharmacology
Exocytosis
Exocytosis - drug effects
Exocytosis - physiology
Feedback, Physiological - drug effects
Feedback, Physiological - physiology
Fundamental and applied biological sciences. Psychology
Fura-2
Glutamic Acid - metabolism
Membrane Fusion - drug effects
Membrane Fusion - physiology
Nerve Tissue Proteins - drug effects
Nerve Tissue Proteins - metabolism
Phosphorylation - drug effects
Potassium Channel Blockers - pharmacology
Potassium Chloride - pharmacology
Presynaptic Terminals - drug effects
Presynaptic Terminals - enzymology
Presynaptic Terminals - secretion
Pyrazoles - pharmacology
Pyridinium Compounds
Pyrimidines - pharmacology
Quaternary Ammonium Compounds
Rats
Src
src-Family Kinases - antagonists & inhibitors
src-Family Kinases - metabolism
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
Synaptic Vesicles - drug effects
Synaptic Vesicles - enzymology
Synaptosomes
Vertebrates: nervous system and sense organs
title Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Src%20family%20tyrosine%20kinases%20differentially%20modulate%20exocytosis%20from%20rat%20brain%20nerve%20terminals&rft.jtitle=Neurochemistry%20international&rft.au=Baldwin,%20Monique%20L.&rft.date=2006-07-01&rft.volume=49&rft.issue=1&rft.spage=80&rft.epage=86&rft.pages=80-86&rft.issn=0197-0186&rft.eissn=1872-9754&rft.coden=NEUIDS&rft_id=info:doi/10.1016/j.neuint.2006.01.002&rft_dat=%3Cproquest_cross%3E17168359%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-ef30bb32fa6f2422c745ddd81564ba5262c8395fcbb01dba3b71e915f4ec842f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17168359&rft_id=info:pmid/16500731&rfr_iscdi=true